Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease

被引:2
|
作者
Mao, Zi-Hui [1 ,2 ,3 ,4 ]
Gao, Zhong-Xiuzi [1 ,2 ,3 ,4 ]
Pan, Shao-Kang [1 ,2 ,3 ,4 ]
Liu, Dong-Wei [1 ,2 ,3 ,4 ]
Liu, Zhang-Suo [1 ,2 ,3 ,4 ]
Wu, Peng [1 ,2 ,3 ,4 ]
机构
[1] Zhengzhou Univ, Tradit Chinese Med Integrated Dept Nephrol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Inst Nephrol, Zhengzhou, Peoples R China
[3] Henan Prov Res Ctr Kidney Dis, Zhengzhou, Peoples R China
[4] Key Lab Precis Diag & Treatment Chron Kidney Dis H, Zhengzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CHAIN AMINO-ACIDS; LIPID-METABOLISM; INTESTINAL MICROBIOTA; MECHANISMS; DEPLETION; PROTECTS; PATHWAY; SULFATE; CELLS; ACSL4;
D O I
10.1038/s41420-024-02000-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ferroptosis is a novel form of lipid peroxidation-driven, iron-dependent programmed cell death. Various metabolic pathways, including those involved in lipid and iron metabolism, contribute to ferroptosis regulation. The gut microbiota not only supplies nutrients and energy to the host, but also plays a crucial role in immune modulation and metabolic balance. In this review, we explore the metabolic pathways associated with ferroptosis and the impact of the gut microbiota on host metabolism. We subsequently summarize recent studies on the influence and regulation of ferroptosis by the gut microbiota and discuss potential mechanisms through which the gut microbiota affects ferroptosis. Additionally, we conduct a bibliometric analysis of the relationship between the gut microbiota and ferroptosis in the context of chronic kidney disease. This analysis can provide new insights into the current research status and future of ferroptosis and the gut microbiota.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Targeting gut microbiota: a potential promising therapy for diabetic kidney disease
    Chen, Zhonge
    Zhu, Shuishan
    Xu, Gaosi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (10): : 4009 - 4016
  • [32] The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
    Huang, Yinghui
    Xin, Wang
    Xiong, Jiachuan
    Yao, Mengying
    Zhang, Bo
    Zhao, Jinghong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Gut microbiota in kidney disease and hypertension
    Antza, C.
    Stabouli, S.
    Kotsis, V.
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 198 - 203
  • [34] Potential mechanisms linking gut microbiota and portal hypertension
    Baffy, Gyorgy
    LIVER INTERNATIONAL, 2019, 39 (04) : 598 - 609
  • [35] Role of ferroptosis in chronic kidney disease
    Li, Shiyang
    Han, Qiuxia
    Liu, Chang
    Wang, Yixue
    Liu, Fengxun
    Pan, Shaokang
    Zuo, Lihua
    Gao, Dan
    Chen, Kai
    Feng, Qi
    Liu, Zhangsuo
    Liu, Dongwei
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [36] Mechanisms of ferroptosis in chronic kidney disease
    Zhuo, Wen-Qing
    Wen, Yi
    Luo, Hui-Jun
    Luo, Zhu-Lin
    Wang, Li
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [37] Role of ferroptosis in chronic kidney disease
    Shiyang Li
    Qiuxia Han
    Chang Liu
    Yixue Wang
    Fengxun Liu
    Shaokang Pan
    Lihua Zuo
    Dan Gao
    Kai Chen
    Qi Feng
    Zhangsuo Liu
    Dongwei Liu
    Cell Communication and Signaling, 22
  • [38] The Potential Role of the Gut Microbiota in Kidney Transplantation
    Huang, Jennifer
    Salinas, Thalia
    Westblade, Lars F.
    Lee, John R.
    KIDNEY360, 2021, 2 (05): : 890 - 893
  • [39] Mitochondrial dysfunction and gut microbiota imbalance: An intriguing relationship in chronic kidney disease
    Mafra, Denise
    Borges, Natalia Alvarenga
    Lindholm, Bengt
    Stenvinkel, Peter
    MITOCHONDRION, 2019, 47 : 206 - 209
  • [40] Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease
    Gao, Yuan
    Wang, Shengnan
    Sun, Lijun
    Li, Bing
    Liu, Hong
    Bu, Ren
    Su, Changhai
    Guo, Min
    Liu, Yang
    Zhao, Lulu
    Gu, Chao
    Li, Xiaojia
    Yuan, Xiaorong
    Wang, Qiwen
    Li, Gang
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (02):